Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

30.68 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,406
Open 30.68
Bid (Size) 30.89 (10)
Ask (Size) 30.99 (1)
Prev. Close 30.68
Today's Range 30.68 - 30.68
52wk Range 8.090 - 31.68
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Hims & Hers Stock Jumped on Massive FDA News
Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model. 
Via The Motley Fool
Exposures Product Safety
Technical Monday: A Fresh Look At The “Vanity” Trade
Nu Skin is an American multi-level marketing company for personal care products and dietary supplements. 
Via Talk Markets
Topics ETFs Stocks / Equities

Performance

YTD
+218.26%
+218.26%
1 Month
+32.93%
+32.93%
3 Month
+106.74%
+106.74%
6 Month
+60.63%
+60.63%
1 Year
+270.98%
+270.98%

More News

Read More
What's Going On With Hims & Hers Health Stock Monday?
Via Benzinga
Topics Government
Exposures Political
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Via Benzinga
Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?
Via Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
Price Over Earnings Overview: Hims & Hers Health
Via Benzinga
Hims & Hers New Growth Category Is a Huge Surprise
Via The Motley Fool
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
From Hims & Hers
Via Business Wire
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
Via The Motley Fool
Guardant Health Stock Sees RS Rating Jump To 83
Via Investor's Business Daily
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
Should You Buy Hims & Hers Stock on the Dip?
Via The Motley Fool
Peering Into Hims & Hers Health's Recent Short Interest
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16
Via Talk Markets
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Via The Motley Fool
From Volatility To Opportunity: Key Stocks Poised To Shine Today
Via Talk Markets
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Via Benzinga
What's Going On With Hims & Hers Health Stock On Wednesday?
Via Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
From Hims & Hers
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
Via The Motley Fool
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.